Where T12 peptide could facilitate blood–brain barrier (BBB) penetration, anti-PD-L1 nanobody was used as a targeting ligand for active targeting and simvastatin was utilized to repolarize the tumor-associated macrophages from the M2 to M1 phenotype for remodeling tumor microenvironments. The gene discussed is CD274; the disease is neoplasm.